申请人:UNIVERSITY OF WOLLONGONG
公开号:EP2343285A2
公开(公告)日:2011-07-13
A compound of the formula (I): wherein
A is an aromatic or heteroaromatic ring system or partially or fully reduced derivatives thereof;
Q is hydrogen, C1-C12 straight chain, branched or cyclic alkyl substituted with one or more hydroxy groups, or a mono- or di-saccharide moiety;
Z is -CR10R11-, -NR12-, -C(O)O-, -C(O)NR12- or -O-, where R10 and R11 are independently selected from hydrogen, hydroxy, C1-C6 alkyl, C6-C10 aryl, C1-C6 alkoxy and -N(R13)2 and where each R13 is independently selected from hydrogen and C1-C6 alkyl, and where R12 is selected from hydrogen and C1-C6 alkyl; R1 is selected from hydrogen, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, -NR(R13)2 and -N(R12)-COR14; where R12 and R13 are as defined above, and where R14 is selected from hydrogen, hydroxy, C1-C6 alkyl, C1-C6 alkoxy and -NR12;
R2 is selected from hydrogen, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, -N(R13)2 and -N(R12)-COCHR2aR2b; where R2a and R2b are selected from hydrogen, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, -N(R13)2 and -N(R12)-COR14; where R12 , R13 and R14 are as defined above;
R3, R4 and R5 are independently selected from hydrogen, C1-C6 alkyl and α side chains of α-amino acids or their enantiomers or their derivatives;
R6 is -CO2R15, -CONHR16, -CONHOR16, -CONHNHR16, -SO2N(R16)2, -SO2R17 or -P(O)(OR18)(OR18) where each R15, R16, R17 and R18 is independently selected from hydrogen, C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl and C7-C10 arylalkyl;
B is an α-amino acid residue, a β-amino acid residue or an α,α-disubstituted amino acid residue, such residue forming amide linkages with the adjacent molecules;
W is -O- or CR10R11 where R10 and R11 are as defined above;
Y is an optionally substituted amino group, a moiety containing an optionally substituted amino group or a salt thereof:
------ is a single or double bond;
R7 and R8a are hydrogen or are absent if ------ is a double bond; and
R8b and R9 are hydrogen, and X is selected from (CR10R11)u, -(CR10R11)u-CH=CH-, -NR12(CR10R11)u-, -(CR10R11)uNR12-, -O(CR10R11)u-, -(CR10R11)uO- or -O(CR10R11)CH=CH- where R10, R11 and R12 are as defined above; or
R8b and R9 together form a covalent bond between X and the carbon to which R8b is attached, and X is selected from (CR10R11)x, -NR12(CR10R11)x-, -(CR10R11)xNR12-, -O(CR10R11)x- or -(CR10R11)xO-, where R10, R11 and R12 are as defined above;
n, m, r and t are independently selected from 0 or 1;
s is an integer selected from 0 to 3;
p is an integer selected from 0 to 6, provided that when W is -O-, p is at least 1; and u, x and q are independently selected from 0 to 4;
and salts and pharmaceutically acceptable derivatives thereof.
The compound of formula (I) are useful in the treatment of bacterial infections.
式 (I) 的化合物: 其中
A 是芳香族或杂芳环系或其部分或全部还原衍生物;
Q 是氢、被一个或多个羟基取代的 C1-C12 直链、支链或环状烷基或单糖或二糖分子;
Z是-CR10R11-、-NR12-、-C(O)O-、-C(O)NR12-或-O-,其中R10和R11独立选自氢、羟基、C1-C6烷基、C6-C10芳基、C1-C6烷氧基和-N(R13)2,每个R13独立选自氢和C1-C6烷基,R12选自氢和C1-C6烷基;R1 选自氢、羟基、C1-C6 烷基、C1-C6 烷氧基、-NR(R13)2 和-N(R12)-COR14;其中 R12 和 R13 如上定义,R14 选自氢、羟基、C1-C6 烷基、C1-C6 烷氧基和-NR12;
R2 选自氢、羟基、C1-C6 烷基、C1-C6 烷氧基、-N(R13)2 和 -N(R12)-COCHR2aR2b;其中 R2a 和 R2b 选自氢、羟基、C1-C6 烷基、C1-C6 烷氧基、-N(R13)2 和 -N(R12)-COR14;其中 R12、R13 和 R14 如上定义;
R3、R4 和 R5 独立选自氢、C1-C6 烷基和 α- 氨基酸或其对映体或其衍生物的 α 侧链;
R6 是-CO2R15、-CONHR16、-CONHOR16、-CONHNHR16、-SO2N(R16)2、-SO2R17 或-P(O)(OR18)(OR18),其中每个 R15、R16、R17 和 R18 独立选自氢、C1-C6 烷基、C3-C7 环烷基、C6-C10 芳基和 C7-C10 芳烷基;
B 是 α-氨基酸残基、β-氨基酸残基或 α,α-二取代氨基酸残基,此类残基与相邻分子形成酰胺连接;
W 是-O-或 CR10R11,其中 R10 和 R11 如上文所定义;
Y 是任选取代的氨基、含有任选取代的氨基的分子或其盐:
------ 是单键或双键;
R7 和 R8a 是氢,如果 ------ 是双键,则不含 R7 和 R8a;以及
R8b和R9为氢,X选自(CR10R11)u、-(CR10R11)u-CH=CH-、-NR12(CR10R11)u-、-(CR10R11)uNR12-、-O(CR10R11)u-、-(CR10R11)uO-或-O(CR10R11)CH=CH-,其中R10、R11和R12如上定义;或
R8b 和 R9 一起在 X 和 R8b 所连接的碳之间形成共价键,且 X 选自 (CR10R11)x、-NR12(CR10R11)x-、-(CR10R11)xNR12-、-O(CR10R11)x- 或 -(CR10R11)xO-,其中 R10、R11 和 R12 如上文所定义;
n、m、r 和 t 分别独立地选自 0 或 1;
s 是选自 0 到 3 的整数;
p 是选自 0 至 6 的整数,条件是当 W 为-O-时,p 至少为 1;以及 u、x 和 q 独立选自 0 至 4;
及其盐类和药学上可接受的衍生物。
式(I)化合物可用于治疗细菌感染。